NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Bio Medica Laboratories

Bio Medica Laboratories

Open Date

May 21, 2026

Close Date

May 25, 2026

listed

Min Investment

₹2,78,000

Lot Size

1000 Shares

Issue Size

₹52.43 Cr

Price Range

₹132 - ₹132

Listing Date

May 29, 2026

IPO Doc

RHP PDF

About Bio Medica Laboratories

The Bio Medica Laboratories deals in the manufacture of parenteral formulations that involve the development and supply of ethical drug products, generics, and over-the-counter drugs in liquid and dry powder forms for injection purposes. Product Portfolio: 58 products are present in liquid injectable forms Dry powder injectable form of products is also supplied with 15 such products It supplies various types of products like generic drugs, proprietary drugs, over the counter drugs, and others. Business Model: The Bio Medica Laboratories function as a business to business organization dealing only in contract manufacturing of its products. It develops formulations of different products as per the requirements of various organizations. It is licensed for good manufacturing practices (GMP) and good laboratory practices (GLP) as certified by the Food & Drugs Administration, Madhya Pradesh. Manufacturing plants: Two plants are located in Indore district of Madhya Pradesh.

Checklist Quality Analysis

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

0GMP

Bio Medica Laboratories IPO - Issue Objectives

The company will utilise ₹6.50 crore for repayment of loan. The company will utilise ₹28.50 crore to setup new manufacturing facility at existing premises Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Repayment of loan

13.7%

Set up of new facility

60.3%

General corporate purposes

25.8%

1

Repayment of loan

The company will utilise ₹6.50 crore for repayment of loan.

13.70%
2

Set up of new facility

The company will utilise ₹28.50 crore to setup new manufacturing facility at existing premises

60.30%
3

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

25.80%

IPO Subscription Status

Retails
2.91x
QIB
15.94x
NII
4.23x

Financials of Bio Medica Laboratories

In Cr.

Contact Details

Bio Medica Laboratories

Plot No. 11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh - 452015.

Bio Medica Laboratories IPO - FAQs

Bio Medica Laboratories IPO is a SME IPO. The issue is priced at 132-₹139. The minimum order quantity is 1000 Shares. The IPO opens on 21 May, and closes on 25 May. TBA is the registrar for the IPO. The shares are proposed to be listed on SME.

Live IPOs

CMR Green Technologies logo

CMR Green Technologies

Mainboard
BSE
NSE
Open  Close3rd Jun 2026 - 5th Jun 2026
Issue Size630.88 Cr
Min. Qty78 Shares
Issue Price₹ 182.00
Live IPO
Vahh Chemicals logo

Vahh Chemicals

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size13.45 Cr
Min. Qty2000 Shares
Issue Price₹ 60.00
Live IPO
UHM Vacation logo

UHM Vacation

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size36.02 Cr
Min. Qty800 Shares
Issue Price₹ 157.00
Live IPO
Hexagon Nutrition logo

Hexagon Nutrition

Mainboard
Open  Close5th Jun 2026 - 9th Jun 2026
Issue Size138.87 Cr
Min. Qty333 Shares
Issue Price₹ 42.00
Live IPO
See All Live IPOs
IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.